|
|
||||||||
1
Department of Pediatrics, St. Louis Children's Hospital, Rm. 3S34, One
Children's PI., St. Louis, MO 63110.
2
Department of Neuroradiology, Mallinckrodt Institute of Radiology, Washington
University Medical Center, Box 8131, 510 S. Kingshighway Blvd., St. Louis, MO
63110.
3
Departments of Pathology and Neuropathology, Washington University School of
Medicine, Box 8118, 660 S. Euclid Ave., St. Louis, MO 63110.
4
Department of Pediatric Neurology, St. Louis Children's Hospital, St. Louis,
MO 63110.
5
Department of Pediatric Neurosurgery, Medical College of Wisconsin, 9000 W.
Wisconsin Ave., P. O. Box 1997, Milwaukee, WI 53201.
6
Department of Pediatrics, Washington University School of Medicine, Box 8116,
St. Louis, MO 63110.
Received December 1, 2000;
accepted after revision February 16, 2001.
Supported by the American Academy of Pediatrics Resident Research
Grant.
Abstract
|
|
|---|
MATERIALS AND METHODS. On the basis of histopathologic evaluation, tumors in this case series were segregated into three types: low-grade gliomas, embryonal tumors, and nonembryonal high-grade tumors. Mean apparent diffusion coefficient and anisotropy values obtained from the solid components of each tumor were compared with cellularity, total cellular area, and total nuclear area derived from biopsy material.
RESULTS. The apparent diffusion coefficient ratio (tumor to normal brain) correlated well with tumor classification (p = 0.001). Anisotropy was decreased similarly in all tumor classifications. The absolute apparent diffusion coefficient correlated well with cellularity (p = 0.014) and total nuclear area (p = 0.005) per high-power field. The correlation between apparent diffusion coefficient and total cellular area per high-power field was not statistically significant.
CONCLUSION. The apparent diffusion coefficient may be predictive of tumor classification and may be a useful tool in characterizing tumor cellularity and total nuclear area. These parameters are not available in standard MR imaging. Therefore, diffusion-tensor imaging may enhance the diagnostic process in pediatric CNS malignancies.
|
|
|---|
Diffusion imaging produces images in which relative intensity is related to microscopic displacement of water molecules [2]. Diffusion-tensor imaging is a more sophisticated quantitative form of diffusion imaging. For diffusion-tensor imaging, water diffusion is measured in several orientations relative to the sample. When these measurements are combined, it is possible to calculate not only an absolute measure of average water diffusion for each voxel (the apparent diffusion coefficient) but also a measure of how water diffusion varies along different axes of the image (diffusion anisotropy). Water diffusion is anisotropic in white matter, for example, with diffusion coefficients measured parallel to nerve fibers being higher than those measured perpendicular to them. Overall, both apparent diffusion coefficient and diffusion anisotropy reflect the microstructure of the tissue in which they are measured.
The purpose of this study was to determine if quantitative diffusion-tensor imaging improves the MR imaging of pediatric CNS malignancies in vivo by comparing the tumor apparent diffusion coefficient to light microscopic features. We hypothesized that the most cellular tumors and those with the least amount of cytoplasm (greater nuclear area) would have the lowest apparent diffusion coefficient values. This information could play an important adjunctive role in the workup and treatment of pediatric CNS neoplasms.
|
|
|---|
We retrospectively screened 35 consecutive patients to identify those who met these criteria. Twelve patients (six boys, five girls, one infant) were included in the subsequent analysis. The diagnoses were histologically confirmed in all patients. The number of each tumor type was small; therefore, we subdivided each tumor into three basic categories: low-grade (World Health Organization, grade I-II) gliomas (n = 4), nonembryonal high-grade (World Health Organization, grade III-IV) tumors (n = 4), and embryonal tumors (n = 4) (Table 1).
|
All examinations were performed on a 1.5-T system (AnalyzeAVW software; Mayo Clinic Foundation, Rochester, MN) with circularly polarized head coils. The diffusion-tensorimaging protocol (TR/TE, 3000.0/97.4) consisted of a single-shot multisection spin-echo echoplanar pulse sequence with a 24 x 24 cm field of view, 5-mm section thickness, and a 1-mm gap between sections [3, 4]. Four tetrahedrally oriented diffusion-weighted images (diffusion sensitivity, b = 1012.4 sec/mm2), three orthogonally oriented diffusion-weighted images (b = 337.5 sec/mm2), and a reference T2-weighted intensity image (b = 0.0 sec/mm2) were obtained at each transverse section. Fourteen transverse sections were acquired in 35 sec with a 96 x 128 voxel matrix (2.50 x 1.88 x 5.00 mm voxels), interpolated to a 192 x 256 pixel matrix. All images were realigned in two dimensions, with a combination of intra- and cross-modality affine realignment procedures, to correct for image displacements and linear stretch and shear due to eddy currents [4]. For technical reasons, the diffusion-tensor images must be oriented in the transverse plane relative to the magnet bore. The diffusion-tensor images were, therefore, not necessarily acquired in register with those of the conventional MR sequences in the clinical neuroimaging protocol, which were oriented along the plane parallel to the anterior commissure and posterior commissure.
For each pixel, the elements of the diffusion tensor were derived from this combination of tetrahedral and perpendicular diffusion measurements [3, 4]. The reference T2-weighted intensity image was not included in the diffusion-tensor calculations because of the presence of artifacts in some studies that arose from spurious free induction decay signal. The apparent diffusion coefficient, a measure of the directionally averaged magnitude of diffusion with units of mm2/sec, was computed as one third of the trace of the diffusion tensor.
The MR images were analyzed as follows: we used T2-weighted images and enhanced T1-weighted images to define the slice to be analyzed, to exclude regions of hemorrhage, and to distinguish cystic from enhancing solid portions of the mass (Figs. 1A,1B,1C,2A,2B,2C,3A,3B,3C). We drew ROIs on the apparent diffusion coefficient and anisotropy maps, using AnalyzeAVW software (Mayo Clinic Foundation, Rochester, MN) in areas of solid tumor (Figs. 1A,1B,1C,2A,2B,2C,3A,3B,3C). As many as three ROIs were drawn on one or two transverse slices. Areas of edema, cystic change, and central necrosis were excluded from the analysis.
|
|
|
|
|
|
|
|
|
ROIs were obtained from contralateral homologous brain regions to serve as control regions. The apparent diffusion coefficient and anisotropy values were computed from the mean of the pixel values obtained for the ROIs placed on these images. When more than one region was drawn, the mean apparent diffusion coefficient and anisotropy values were calculated from all regions and averaged by the number of pixels. The ratio of the apparent diffusion coefficient to contralateral control brain region was then computed (apparent diffusion coefficient ratio) (Table 1). This computation was performed because apparent diffusion coefficient values of normal brain vary with age [5], and the contrast achieved between tumor and surrounding tissue depends on this ratio. One author drew all ROIs, and proper placement was confirmed by a consensus of a board-certified radiologist and an attending neuroradiologist with a certificate of added qualification in neuroradiology.
A board-certified attending neuropathologist performed the histopathologic analysis. Tumor cellularity was defined as the number of cells across a single representative high-power field (Fig. 4A,4B,4C,4D). We measured average cellular and nuclear diameters for each tumor, using an ocular micrometer. Total cellular area was computed from the measured cell area of each tumor cell type multiplied by the number of cells per high-power field. Total nuclear area was computed from the measured nuclear area of each tumor cell type multiplied by the number of cells per high-power field. The neuropathologist was blinded to the MR imaging findings and the apparent diffusion coefficient values for each tumor. We made statistical comparisons of apparent diffusion coefficient ratio to normal brain with tumor type, using one-way analysis of variance. Statistical comparisons of the absolute apparent diffusion coefficient values with tumor cellularity and with total nuclear area were made with linear regression analysis and Pearson's correlation coefficient. Absolute apparent diffusion coefficient values were used for this comparison to evaluate the possibility that apparent diffusion coefficient values change with these parameters. Ratios to normal brain tissue were not used in this case because it is unlikely that apparent diffusion coefficient values change with the age of the subject (i.e., with the apparent diffusion coefficient values of normal brain).
|
|
|
|
|
|
|---|
|
|
|
|
|
|---|
In our study, the apparent diffusion coefficient correlated significantly with both the tumor cellularity and the calculated total nuclear area. The apparent diffusion coefficient of the 13-year-old girl with medulloblastoma was seen as an outlier in the tumor cellularity graph. This feature can likely be explained by the large cell pathology of this medulloblastoma. This patient had a high calculated total nuclear area but had lower cellularity (Fig. 4D). This tumor displayed restricted diffusion presumably because of the densely packed nature of the tumor cells and the high nuclear-to-cytoplasm ratio.
To our knowledge, published data characterizing diffusion in pediatric brain tumors are limited. Several studies have shown that different components of tumor, surrounding edema, and normal surrounding white matter have different apparent diffusion coefficient values [16,17,18,19,20,21]. Cystic and necrotic portions of tumor have higher apparent diffusion coefficient values, reflecting the increased water movement characterizing these components. Tien et al. [17] used diffusion-weighted imaging along a single axis to show that enhancing components of highgrade gliomas have a lower apparent diffusion coefficient than nonenhancing tumor and peritumoral edema. Brunberg et al. [19] found a distinction between apparent diffusion coefficient and diffusion anisotropy from normal white matter and solid enhancing tumor, cystic and necrotic areas, and regions of edema. They did not find a difference in apparent diffusion coefficient values between various glioma subtypes. Sugahara et al. [2] showed a trend similar to our study by comparing high- and low-grade gliomas to cellularity defined as the total area of nuclei of tumor cells divided by the area of histologic section. They concluded that apparent diffusion coefficient correlated with tumor cellularity.
A previous case report postulated that the densely cellular nature and high nuclear-to-cytoplasmic ratio of medulloblastoma restricts extracellular diffusion of water [22]. However, no quantitative data were presented to support this hypothesis. Our data support this hypothesis by showing that these tumors have apparent diffusion coefficient values of less than 1.0 x 10-3 mm2/sec, consistent with reduced diffusion.
Chenevert et al. [23] used a ratbrain tumor model to show that diffusion measurements are sensitive to chemotherapy induced changes. Apparent diffusion coefficient values were obtained pretreatment, after treatment, and during tumor regrowth. Results indicated that the apparent diffusion coefficient values increase with therapy and return to the pretreatment levels during tumor regrowth. The increase in apparent diffusion coefficient during therapy suggests an increase in interstitial volume and cellular permeability from tumor-cell necrosis. Further investigation along these lines could lead to new ways of evaluating tumor response to therapy.
Our study is limited by the small number of patients and by the heterogeneous sample of tumors. ROIs analyzed on MR images may not precisely correspond to the biopsy specimens used in the pathologic evaluations. Finally, our values for the total nuclear area are calculated estimates and are not actual measurements. Despite these limitations, we believe that the observations are potentially clinically significant. All studies were performed preoperatively, and thus, there were no influences of surgery or prior therapy. Further studies in this pediatric population are needed to determine the role of this modality in clinical decision-making.
In conclusion, we found that apparent diffusion coefficients of pediatric brain tumors are significantly correlated with tumor cellularity and total nuclear area. Quantitative diffusion imaging may enhance the diagnostic process and may be predictive of patient clinical outcome before tissue sampling of pediatric CNS malignancies.
Acknowledgments
We thank Thomas K. Pilgram for expert advice on the statistical analyses
used in this investigation.
|
|
|---|
This article has been cited by other articles:
![]() |
S. Kim, M. Jain, A. B. Harris, V. S. Lee, J. S. Babb, E. E. Sigmund, L. E. Rueff, and B. Taouli T1 Hyperintense Renal Lesions: Characterization with Diffusion-weighted MR Imaging versus Contrast-enhanced MR Imaging Radiology, June 1, 2009; 251(3): 796 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Taouli, R. K. Thakur, L. Mannelli, J. S. Babb, S. Kim, E. M. Hecht, V. S. Lee, and G. M. Israel Renal Lesions: Characterization with Diffusion-weighted Imaging versus Contrast-enhanced MR Imaging Radiology, May 1, 2009; 251(2): 398 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
T NIWA, M UENO, S OHKAWA, T YOSHIDA, T DOIUCHI, K ITO, and T INOUE Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy Br. J. Radiol., January 1, 2009; 82(973): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mukherjee, J.I. Berman, S.W. Chung, C.P. Hess, and R.G. Henry Diffusion Tensor MR Imaging and Fiber Tractography: Theoretic Underpinnings AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 632 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-M. Koh and D. J. Collins Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology Am. J. Roentgenol., June 1, 2007; 188(6): 1622 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Murakami, T. Sugahara, H. Nakamura, T. Hirai, M. Kitajima, Y. Hayashida, Y. Baba, N. Oya, J.-i. Kuratsu, and Y. Yamashita Malignant Supratentorial Astrocytoma Treated with Postoperative Radiation Therapy: Prognostic Value of Pretreatment Quantitative Diffusion-weighted MR Imaging Radiology, May 1, 2007; 243(2): 493 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Higano, X. Yun, T. Kumabe, M. Watanabe, S. Mugikura, A. Umetsu, A. Sato, T. Yamada, and S. Takahashi Malignant Astrocytic Tumors: Clinical Importance of Apparent Diffusion Coefficient in Prediction of Grade and Prognosis Radiology, December 1, 2006; 241(3): 839 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashida, T. Hirai, S. Morishita, M. Kitajima, R. Murakami, Y. Korogi, K. Makino, H. Nakamura, I. Ikushima, M. Yamura, et al. Diffusion-weighted Imaging of Metastatic Brain Tumors: Comparison with Histologic Type and Tumor Cellularity AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1419 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Rumboldt, D.L.A. Camacho, D. Lake, C.T. Welsh, and M. Castillo Apparent Diffusion Coefficients for Differentiation of Cerebellar Tumors in Children AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1362 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Provenzale, S. Mukundan, and D. P. Barboriak Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response. Radiology, June 1, 2006; 239(3): 632 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.J. Helton, N.S. Phillips, R.B. Khan, F.A. Boop, R.A. Sanford, P. Zou, C.S. Li, J.W. Langston, and R.J. Ogg Diffusion tensor imaging of tract involvement in children with pontine tumors. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 786 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasu, Y. Kuroki, S. Nawano, S. Kuroki, T. Tsukamoto, S. Yamamoto, K. Motoori, and T. Ueda Hepatic Metastases: Diffusion-weighted Sensitivity-encoding versus SPIO-enhanced MR Imaging Radiology, April 1, 2006; 239(1): 122 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Donaldson, F. Laningham, and P. G. Fisher Advances Toward an Understanding of Brainstem Gliomas J. Clin. Oncol., March 10, 2006; 24(8): 1266 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Field Diffusion Tensor Imaging at the Crossroads: Fiber Tracking Meets Tissue Characterization in Brain Tumors AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2168 - 2169. [Full Text] [PDF] |
||||
![]() |
M. Bozzali, A. Falini, M. Cercignani, F. Baglio, E. Farina, M. Alberoni, P. Vezzulli, F. Olivotto, F. Mantovani, T. Shallice, et al. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study Brain, July 1, 2005; 128(7): 1595 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yamasaki, K. Kurisu, K. Satoh, K. Arita, K. Sugiyama, M. Ohtaki, J. Takaba, A. Tominaga, R. Hanaya, H. Yoshioka, et al. Apparent Diffusion Coefficient of Human Brain Tumors at MR Imaging Radiology, June 1, 2005; 235(3): 985 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Tung and J. M. Rogg Diffusion-Weighted Imaging of Cerebritis AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1110 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Stadnik, P. Demaerel, R. R Luypaert, C. Chaskis, K. L. Van Rompaey, A. Michotte, and M. J. Osteaux Imaging Tutorial: Differential Diagnosis of Bright Lesions on Diffusion-weighted MR Images RadioGraphics, January 1, 2003; 23(1): e7 - e7. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |